Cargando…
A Histone Deacetylase (HDAC) Inhibitor with Pleiotropic In Vitro Anti-Toxoplasma and Anti-Plasmodium Activities Controls Acute and Chronic Toxoplasma Infection in Mice
Toxoplasmosis is a highly prevalent human disease, and virulent strains of this parasite emerge from wild biotopes. Here, we report on the potential of a histone deacetylase (HDAC) inhibitor we previously synthesized, named JF363, to act in vitro against a large panel of Toxoplasma strains, as well...
Autores principales: | Jublot, Delphine, Cavaillès, Pierre, Kamche, Salima, Francisco, Denise, Fontinha, Diana, Prudêncio, Miguel, Guichou, Jean-Francois, Labesse, Gilles, Sereno, Denis, Loeuillet, Corinne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952293/ https://www.ncbi.nlm.nih.gov/pubmed/35328672 http://dx.doi.org/10.3390/ijms23063254 |
Ejemplares similares
-
A Tiny Change Makes a Big Difference in the Anti-Parasitic Activities of an HDAC Inhibitor
por: Loeuillet, Corinne, et al.
Publicado: (2019) -
Toxoplasma Hypervirulence in the Rat Model Parallels Human Infection and Is Modulated by the Toxo1 Locus
por: Loeuillet, Corinne, et al.
Publicado: (2019) -
Synthesis of aminophenylhydroxamate and aminobenzylhydroxamate derivatives and in vitro screening for antiparasitic and histone deacetylase inhibitory activity
por: Loeuillet, C., et al.
Publicado: (2018) -
In vitro and in vivo anti−Toxoplasma activities of HDAC inhibitor Panobinostat on experimental acute ocular toxoplasmosis
por: Zhang, Yu, et al.
Publicado: (2022) -
In vivo anti-Toxoplasma activity of aripiprazole
por: Saraei, Mehrzad, et al.
Publicado: (2015)